NCT03611270 - TReatment of Pulmonary Hypertension Group II Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2018

Primary Completion Date

December 1, 2023

Study Completion Date

July 31, 2027

Conditions

Pulmonary Hypertension (PH) Due to Left Heart Disease

Interventions

DEVICE

Pulmonary Denervation

Pulmonary Denervation (PDN) using the TIVUS™ System will be performed in patient suffering from pulmonary hypertension after completion of screening and eligibility phase, The procedure will be performed during right heart catheterisation. Safety and effectiveness of the PDN treatment will be assessed during one year follow up.

Trial Locations (3)

92037

UC San Diego Medical Center, San Diego

94158

University of California, San Francisco Medical Center, San Francisco

02114-2696

Massachusetts General Hospital, Boston

All Listed Sponsors

lead

SoniVie Inc.

INDUSTRY